Accès gratuit
Méd. Intensive Réa.
Volume 26, Numéro 3, Mai 2017
Page(s) 196 - 206
Section Mise au point / Update
Publié en ligne 31 mars 2017
  • Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P, (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841–842 [CrossRef] [PubMed] [Google Scholar]
  • Basso C, Calabrese F, Corrado D, Thiene G, (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50: 290–300 [PubMed] [Google Scholar]
  • Oliva A, Grassi VM, Campuzano O, Brion M, Arena V, Partemi S, Coll M, Pascali VL, Brugada J, Carracedo A, Brugada R, (2016) Medico-legal perspectives on sudden cardiac death in young athletes. Int J Legal Med 131:393–409 [CrossRef] [PubMed] [Google Scholar]
  • Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK, (1999) The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Med (Baltimore) 78: 270–283 [CrossRef] [Google Scholar]
  • Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA, (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312: 885–890 [CrossRef] [PubMed] [Google Scholar]
  • Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW, (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320–1323 [CrossRef] [PubMed] [Google Scholar]
  • Kawai C, Matsumori A, (2013) Dilated cardiomyopathy update: infectious-immune theory revisited. Heart Fail Rev 18: 703–714 [PubMed] [Google Scholar]
  • Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C, (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35: 537–544 [CrossRef] [PubMed] [Google Scholar]
  • Liu PP, Mason JW, (2001) Advances in the understanding of myocarditis. Circulation 104: 1076–1082 [CrossRef] [PubMed] [Google Scholar]
  • Xie Y, Chen R, Zhang X, Chen P, Liu X, Xie Y, Yu Y, Yang Y, Zou Y, Ge J, Chen H, (2011) The role of Th17 cells and regulatory T cells in Coxsackie virus B3-induced myocarditis. Virology 421: 78–84 [CrossRef] [PubMed] [Google Scholar]
  • Matsumoto Y, Park IK, Kohyama K, (2009) Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy. J Immunol 183: 4773–4781 [PubMed] [Google Scholar]
  • Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L, (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28: 1326–1333 [CrossRef] [PubMed] [Google Scholar]
  • Myers JM, Cooper LT, Kem DC, Stavrakis S, Kosanke SD, Shevach EM, Fairweather D, Stoner JA, Cox CJ, Cunningham MW, (2016) Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. 1: pii: e85851 [Google Scholar]
  • Bock CT, Klingel K, Kandolf R, (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362: 1248–1249 [CrossRef] [PubMed] [Google Scholar]
  • Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kühl U, Kandolf R, Schultheiss HP, (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879–886 [CrossRef] [PubMed] [Google Scholar]
  • Cooper LT, (2009) Myocarditis. N Engl J Med 360: 1526–1538 [CrossRef] [PubMed] [Google Scholar]
  • Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP, (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965–1970 [CrossRef] [PubMed] [Google Scholar]
  • Cooper LT, Berry GJ, Shabetai R, for the Multicenter Giant Cell Myocarditis Study Group Investigators, (1997) Idiopathic giant-cell myocarditis: natural history and treatment. N Engl J Med 336: 1860–1866 [CrossRef] [PubMed] [Google Scholar]
  • Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM, (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36: 227–232 [CrossRef] [PubMed] [Google Scholar]
  • Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, Nguyen C, Cohen A, Slama MS, Steg PG, Le Guludec D, (2001) Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 37: 786–792 [CrossRef] [PubMed] [Google Scholar]
  • Narula J, Khaw BA, Dec GW, Palacios IF, Southern JF, Fallon JT, Strauss HW, Haber E, Yasuda T, (1993) Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 328: 100–104 [CrossRef] [PubMed] [Google Scholar]
  • Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, Thiene G, (2000) Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84: 245–250 [PubMed] [Google Scholar]
  • Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34: 2636–2648, 2648a–2648d [CrossRef] [PubMed] [Google Scholar]
  • Smith SC, Ladenson JH, Mason JW, Jaffe AS, (1997) Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95: 163–168 [CrossRef] [PubMed] [Google Scholar]
  • Mirabel M, Luyt CE, Leprince P, Trouillet JL, Léger P, Pavie A, Chastre J, Combes A, (2011) Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 39: 1029–1035 [CrossRef] [PubMed] [Google Scholar]
  • Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA, (2003) Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42: 466–472 [CrossRef] [PubMed] [Google Scholar]
  • Pankuweit S, Portig I, Lottspeich F, Maisch B, (1997) Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29: 77–84 [CrossRef] [PubMed] [Google Scholar]
  • Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EG, Schoen FJ, (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1: 3–14 [PubMed] [Google Scholar]
  • Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, Bruneval P, Burke M, Butany J, Calabrese F, d'Amati G, Edwards WD, Fallon JT, Fishbein MC, Gallagher PJ, Halushka MK, McManus B, Pucci A, Rodriguez ER, Saffitz JE, Sheppard MN, Steenbergen C, Stone JR, Tan C, Thiene G, van der Wal AC, Winters GL, (2012) 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21: 245–274 [Google Scholar]
  • Holzmann M, Nicko A, Kühl U, Noutsias M, Poller W, Hoffmann W, Morguet A, Witzenbichler B, Tschöpe C, Schultheiss HP, Pauschinger M, (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3,048 diagnostic procedures over an 11-year period. Circulation 118: 1722–1728 [CrossRef] [PubMed] [Google Scholar]
  • Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu CY, McCrohon J, Higgins DM, Carr-White G, Mayr M, Nagel E, Puntmann VO, (2015) Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 8: 37–46 [CrossRef] [PubMed] [Google Scholar]
  • Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, Kandolf R, Sechtem U, Mahrholdt H, (2012) Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 59: 1604–1615 [CrossRef] [PubMed] [Google Scholar]
  • Diddle JW, Almodovar MC, Rajagopal SK, Rycus PT, Thiagarajan RR, (2015) Extracorporeal membrane oxygenation for the support of adults with acute myocarditis: Crit Care Med 43: 1016–1025 [CrossRef] [PubMed] [Google Scholar]
  • Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, Pavie A, Chastre J, (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36: 1404–1411 [CrossRef] [PubMed] [Google Scholar]
  • Lorusso R, Centofanti P, Gelsomino S, Barili F, Di Mauro M, Orlando P, Botta L, Milazzo F, Actis Dato G, Casabona R, Casali G, Musumeci F, De Bonis M, Zangrillo A, Alfieri O, Pellegrini C, Mazzola S, Coletti G, Vizzardi E, Bianco R, Gerosa G, Massetti M, Caldaroni F, Pilato E, Pacini D, Di Bartolomeo R, Marinelli G, Sponga S, Livi U, Mauro R, Mariscalco G, Beghi C, Miceli A, Glauber M, Pappalardo F, Russo CF; GIROC Investigators, (2016) Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg 101: 919–926 [Google Scholar]
  • Hsu KH, Chi NH, Yu HY, Wang CH, Huang SC, Wang SS, Ko WJ, Chen YS, (2011) Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center’s experience. Eur J Cardiothorac Surg 40: 682–688 [PubMed] [Google Scholar]
  • McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL, (2000) Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis. N Engl J Med 342: 690–695 [CrossRef] [PubMed] [Google Scholar]
  • Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE; the Myocarditis Treatment Trial Investigators, (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333: 269–275 [CrossRef] [PubMed] [Google Scholar]
  • Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A, (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107: 857–863 [CrossRef] [PubMed] [Google Scholar]
  • Frustaci A, Russo MA, Chimenti C, (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30: 1995–2002 [CrossRef] [PubMed] [Google Scholar]
  • Escher F, Kühl U, Lassner D, Poller W, Westermann D, Pieske B, Tschöpe C, Schultheiss HP, (2016) Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy. Clin Res Cardiol 105: 1011–1020 [Google Scholar]
  • McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM, (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103: 2254–2259 [CrossRef] [PubMed] [Google Scholar]
  • Tomioka N, Kishimoto C, Matsumori A, Kawai C, (1986) Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol 7: 868–872 [CrossRef] [PubMed] [Google Scholar]
  • Meune C, Spaulding C, Mahé I, Lebon P, Bergmann JF, (2003) Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf 26: 975–981 [CrossRef] [PubMed] [Google Scholar]
  • Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP, (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793–2798 [CrossRef] [PubMed] [Google Scholar]
  • Kühl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss HP, (2012) Interferon-beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 60: 1295–1296 [CrossRef] [PubMed] [Google Scholar]
  • Schultheiss HP, Piper C, Sowade O, Waagstein F, Kapp JF, Wegscheider K, Groetzbach G, Pauschinger M, Escher F, Arbustini E, Siedentop H, Kuehl U, (2016) Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol 105: 763–773 [Google Scholar]
  • Kawano S, Kato J, Kawano N, Yoshimura Y, Masuyama H, Fukunaga T, Sato Y, Maruyama H, Mihara K, Ueda A, Toyoda K, Imamura T, Kitamura K, (2011) Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 50: 975–981 [PubMed] [Google Scholar]
  • Cooper LT, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW; Giant Cell Myocarditis Treatment Trial Investigators, (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102: 1535–1539 [CrossRef] [PubMed] [Google Scholar]
  • Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Struhman I, Hilfiker-Kleiner D, (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121: 1465–1473 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.